SeaStar Medical (NASDAQ:ICU) Trading Down 1.7%

Shares of SeaStar Medical Holding Co. (NASDAQ:ICUGet Rating) traded down 1.7% during mid-day trading on Tuesday . The company traded as low as $0.59 and last traded at $0.61. 350,553 shares were traded during trading, a decline of 29% from the average session volume of 494,263 shares. The stock had previously closed at $0.62.

Analyst Ratings Changes

Separately, Maxim Group assumed coverage on shares of SeaStar Medical in a report on Thursday, April 20th. They set a “buy” rating and a $5.00 target price on the stock.

SeaStar Medical Price Performance

The firm’s fifty day moving average price is $1.77 and its two-hundred day moving average price is $3.34.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in SeaStar Medical stock. Geode Capital Management LLC bought a new position in SeaStar Medical Holding Co. (NASDAQ:ICUGet Rating) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund bought 15,480 shares of the company’s stock, valued at approximately $63,000. Geode Capital Management LLC owned approximately 0.12% of SeaStar Medical as of its most recent filing with the Securities & Exchange Commission.

About SeaStar Medical

(Get Rating)

SeaStar Medical Holding Corporation, a medical device company, focuses on providing novel solutions and services to treat hyperinflammation and cytokine storm in critically ill patients. The company is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses.

Featured Stories

Receive News & Ratings for SeaStar Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SeaStar Medical and related companies with MarketBeat.com's FREE daily email newsletter.